Since the inaugural congress in 2001, this meeting has become the premier forum for discussion of the latest advances in the field of MyeloProliferative Neoplasms (MPNs) . This year, we will focus on timely topics of interest to hematologists and oncologists who treat patients with these rare disorders. The congress program format will utilize case presentations to highlight the essential features of MPN pathophysiology, diagnosis and management, as well as the roles of next-generation...
Read More
